Skip to main content
Equibles
ZTS logo

ZTS · Zoetis Inc. · Metrics

Track ZTS — free

Use ZTS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ZTS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$81.03 -0.97 (-1.18%) At close · Oct 23
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$33.48B
Shares
413.22M
Volume · Oct 23 2.86M Avg daily vol (3M) 5.13M

ZTS metrics

103 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$81.03
Market cap
$33.48B

Price action

20 metrics
Price change (1W)
+2.1%
Price change (30D)
+14.0%
Price change (3M)
+7.5%
Price change (6M)
-30.7%
Price change (YTD)
-35.6%
Price change (1Y)
-44.6%
Trailing year
Price change (5Y)
-61.1%
52-week high
$147.53
52-week low
$69.10
Change from 52-week high
-45.1%
Change from 52-week low
+17.3%
Annualized volatility
38.4%
Annualized volatility (3M)
31.1%
Beta
0.6
RSI (14D)
68.8
Price vs SMA 50
+8.6%
Price vs SMA 200
-14.4%
Avg volume (3M)
5.13M
Relative volume
0.6
Average dollar volume
$384.08M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
413.22M

Valuation

12 metrics
P / E (TTM)
13.2
Trailing earnings · reciprocal yield 7.6%
PEG ratio
10.8
EV / revenue
4.2×
reciprocal yield 23.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
3.5×
reciprocal yield 28.4%
P / book
10.6
reciprocal yield 9.4%
FCF yield
6.9%
TTM · current market cap
Buyback yield
10.9%
P / FCF
14.5
reciprocal yield 6.9%
P / operating cash flow
11.8
reciprocal yield 8.5%
Earnings yield
7.9%

Historical valuation

8 metrics
P / E historical average (3Y)
27.8×
reciprocal yield 3.6%
P / E historical average (5Y)
32.4×
reciprocal yield 3.1%
EV / revenue historical average (3Y)
8.3×
reciprocal yield 12.0%
EV / revenue historical average (5Y)
9.5×
reciprocal yield 10.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
2.6%
Trailing 12 months
Payout ratio
—
Shareholder yield
10.9%
Dividend / share (TTM)
$2.09
Dividend growth YoY
+8.2%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-07-20

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
71.7%
Operating margin
—
Trailing 12 months
Net margin
27.7%
Gross profit (TTM)
$6.83B
Operating profit (TTM)
—
Net income (TTM)
$2.64B
Trailing 12 months
Diluted EPS (TTM)
$6.12
FCF margin
24.3%
Effective tax rate
20.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$22.14
Gross profit per diluted share (TTM)
$15.87
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$6.13
Operating cash flow per diluted share (TTM)
$6.56
Free cash flow per diluted share (TTM)
$5.35
Capital expenditures per diluted share (TTM)
$1.21
R&D per diluted share (TTM)
$1.68
Stock compensation per diluted share (TTM)
$0.22
Book value per share
$8.04

Growth

11 metrics
Revenue growth YoY
-0.2%
Year over year
Net income growth YoY
-4.8%
Revenue (TTM)
$9.53B
Trailing 12 months
EPS growth YoY
+1.2%
Shares change YoY
-6.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.4%
Revenue CAGR (5Y)
+7.2%
EPS CAGR (3Y)
+10.3%
EPS CAGR (5Y)
+12.0%
FCF CAGR (3Y)
+19.9%
FCF CAGR (5Y)
+6.4%

Quality

14 metrics
Return on equity
83.8%
Return on assets
17.5%
Debt / equity
2.6
Current ratio
3.1
EBITDA (TTM)
—
Free cash flow (TTM)
$2.32B
Quick ratio
1.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$6.59B
Latest balance sheet
Cash & equivalents
$1.48B
Total assets
$15.08B
Total debt
$9.04B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.84B
Capital expenditures (TTM)
$524.00M
R&D (TTM)
$723.00M
SG&A (TTM)
$2.37B
Stock compensation (TTM)
$95.00M
R&D / revenue
7.6%
Stock compensation / revenue
1.0%

Ownership (13F)

9 metrics
13F filers
1,447
13F filer change QoQ
-180
Institutional ownership
98.3%
Conviction holders (share of 13F filers)
0.7%
Crowding (high-turnover and private-fund holders)
16.0%
Private-fund adviser ownership
14.0%
Active holders' share change QoQ
-4.1%
Holder tenure
16.7
Price vs estimated holder cost
-39.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
24.0%

Short interest

3 metrics
Short interest
4.5%
Latest settlement · 4.1 days to cover
Days to cover
4.1d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1555280 CUSIP 98978V103 13F (30d) 349 filings 329 filers Visit website Investor relations